Tiny beads, big relief: a knee-pain breakthrough that could delay replacement
Genicular artery embolization (GAE) is a minimally invasive outpatient procedure that reduces pain in knee osteoarthritis by cutting inflamed blood flow to abnormal vessels. About 70% of patients report substantial pain relief, with some experiences nearing normal function; relief can last years (Japan data up to 4 years; U.S. data up to 2 years for good responders). The procedure takes 1–2 hours under conscious sedation with same-day discharge. It’s mainly for mild-to-moderate OA, though benefits may be shorter with advanced disease. Trials at CU Anschutz are exploring mechanisms and broader applications, and related devices have received FDA breakthrough status since 2021.
